Publications

Bhawana B, Lea I, Liu Y, Martini C, Fostel J. Access to National Toxicology Program histopathology lesion collection in Chemical Effects in Biological Systems (CEBS) database. Poster P040. Presented at the 38th Annual Symposium of Society for Toxicologic Pathology, Raleigh, NC, June 2019.

Marsh GM, Ierardi AM, Benson SM, Finley BL. 2019. Occupational exposures to cosmetic talc and risk of mesothelioma: An updated pooled cohort and statistical power analysis with consideration of latency period. Inhal Toxicol 31(6):213–223; doi: 10.1080/08958378.2019.1645768. PMID: 31380702.

Wikoff D, Erranguntla N, Lewis J, Foreman J. A fit-for-purpose framework for use of systematic methods in risk assessment. Poster at Evidence Integration in Chemical Assessments: Challenges Faced in Developing and Communicating Human Health Effect Conclusions. National Academies of Sciences, Engineering, and Medicine, Washington, DC, June 2019.

Urban J, Wikoff D, Haws L. Three-tiered approach to integrating evidence streams assessing gestational trichloroethylene exposure and congenital heart defects (TCE-CHD). Poster at Evidence Integration in Chemical Assessments: Challenges Faced in Developing and Communicating Human Health Effect Conclusions, National Academies of Sciences, Engineering, and Medicine, Washington, DC, June 2019.

Borghoff S, Fitch S, Britt J, Franke K, Wikoff D. Application of the EFSA/ECHA endocrine disruption guidance as a framework for evidence integration in a weight-of-evidence (WoE) analysis for oxybenzone (BP-3). Poster at Evidence Integration in Chemical Assessments: Challenges Faced in Developing and Communicating Human Health Effect Conclusions. National Academies of Sciences, Engineering, and Medicine, Washington, DC, June 2019.

Heintz MM, Kumar R, Rutledge M, Baldwin WS. 2019. Cyp2b-null male mice are susceptible to diet-induced obesity and perturbations in lipid homeostasis. J Nutr Biochem 70(August):125–137; doi: 10.1016/j.jnutbio.2019.05.004. PMID: 31202118.

Zucker RM, Rogers JM. 2019. Confocal laser scanning microscopy of morphology and apoptosis in organogenesis-stage mouse embryos. Meth Mol Biol 1965:297–311; doi: 10.1007/978-1-4939-9182-2_20. PMID: 31069683.

Choksi NY, Truax J, Layton A, Matheson J, Mattie D, Varney T, et al. 2019. United States regulatory requirements for skin and eye irritation testing. Cutan Ocul Toxicol 38(2):141–155; doi: 10.1080/15569527.2018.1540494. PMID: 30418044.

Rogers JM. 2019. Smoking and pregnancy: Epigenetics and the developmental origins of the metabolic syndrome. Birth Defects Res 111(17):1259–1269; doi: 10.1002/bdr2.1550. PMID: 31313499.

Thomas RS, Bahadori T, Buckley T, Cowden J, Deisenroth C, Dionisio K, Frithsen J,…, Patlewicz G, et al. 2019. The next generation of computational toxicology at the US Environmental Protection Agency. Toxicol Sci 169(2):317-332; doi: 10.1093/toxsci/kfz058. PMID: 30835285.

Towle KM, Riordan AS, Pierce JS, Finley BL, Hollins DM. Exposure to asbestos and risk of ovarian cancer: A systematic literature review and meta-analysis. Poster presentation at American Industrial Hygiene Conference & Exposition (AIHce), Minneapolis, MN, 2019.

Ierardi AM, Urban A, Jacobs NFB, McMenamy C, Finley BL, Gaffney SH. Characterization of airborne asbestos exposures from the use of dental products: A comprehensive review. Poster presentation at American Industrial Hygiene Conference & Exposition (AIHce), Minneapolis, MN, 2019.

Covington TR, Ott DK, Gearhart JM, Pangburn HA. Simulating a virtual high-performance aircraft pilot using physiologically-based pharmacokinetic modeling. Poster presented at Annual Meeting of the Aerospace Medical Association, Las Vegas, NV, May 2019.

Frankenfeld CL. Two perspectives on the relationship between the human gut microbiome and diet. Fred Hutchinson Cancer Research Center Nutrition and Physical Activity Affinity Group Seminar, May 23, 2019.

Seo JE, Tryndyak V, Wu Q, Dreval K, Pogribny I, Bryant M, Zhou T, Robison TW, et al. 2019. Quantitative comparison in vitro genotoxicity between metabolically competent HepaRG cells and HepG2 cells using the high-content Comet Chip assay. Arch Toxicol 93(5):1433-1448; doi: 10.1007/s00204-019-02406-9. PMID: 30788552.

Malone D, Miller B, Dean R, Arjunji R, Jensen IS, Maru B, Dabbous O. 2019. Abstract PRO10: Use of single dose gene-replacement therapy for the treatment of spinal muscular atrophy type 1: A United States payer budget impact analysis. Value in Health 22(Sup2):S336-S337; doi: 10.1016/j.jval.2019.04.1644.

Malone DC, Dean R, Miller B, Arjunji R, Feltner DE, Sproule D, Jensen IS, Maru B, Dabbous O. 2019. Abstract ND2: Cost-utility analysis of single dose gene-replacement therapy for spinal muscular atrophy type 1 compared to chronic nusinersen treatment. Value in Health 22(Sup 2):S42-S43; doi: 10.1016/j.jval.2019.04.060.

Arjunji R, Dean R, Jensen IS, Miller B, Menier M, Sproule DM, Feltner DE, Droege M, et al. 2019. Abstract PBI10: Type I spinal muscular atrophy patients treated with AVXS-101 have lower use of ventilatory support, hospitalization, and associated costs compared to those treated with nusinersen. Value in Health 22(Sup 2):S48; doi: 10.1016/j.jval.2019.04.093.

Su J, Bylsma LC, Jiang X, Morales Arias J, Jain N, Nordyke RJ. Healthcare resource utilization among commercially insured cold agglutinin disease patients in the United States. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research, New Orleans, LA, May 2019.

Sacks NC, Cyr PL, Green S, Wood D, Pokorney S. Healthcare resource use and costs following catheter ablation in paroxysmal supraventricular tachycardia (PSVT) patients age <65. Podium presentation, International Society for Pharmacoeconomics and Outcomes Research. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting, New Orleans, LA, May 2019.